European Commission approves subcutaneous amivantamab for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer
It has been announced that the European Commission (EC) has approved an extension of marketing…
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
It has been announced that the European Commission (EC) has approved an extension of marketing…
Results of a VHIO-led study show that up to 90% of chronically hypoxic patients have…
Researchers have found new compounds that could be used to treat a common breast cancer…
Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In…
Breast cancer mortality rates are disproportionately higher in low- to middle-income countries (LMIC) than in…
In a study of the immune systems of mice, scientists at Johns Hopkins Medicine say…
A new editorial, “Deep learning-based uncertainty quantification for quality assurance in hepatobiliary imaging-based techniques,” was…
Modern cancer treatments have evolved beyond traditional chemotherapy to include targeted approaches such as immunotherapy,…
Researchers from the Agency for Science, Technology and Research (A*STAR) and the National Healthcare Group…
New Australian technology is set to transform the way that gastrointestinal cancers are detected and…